EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1

Alexander Muik, Jasmin Quandt, Bonny Gaby Lui, Maren Bacher, Sebastian Lutz, Maika Grünenthal, Aras Toker, Jessica Grosser, Orkun Ozhelvaci, Olga Blokhina, Svetlana Shpyro, Isabel Vogler und 3 weitere

Cell Reports · 2024

DOI: 10.1016/j.celrep.2024.114567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Alexander Muik und 14 weiteren Autor:innen. Beteiligte Einrichtung: BioNTech, An der Goldgrube 12, 55131 Mainz, Germany. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Spike Glycoprotein, Coronavirus, Antibodies, Viral. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Spike Glycoprotein, CoronavirusAntibodies, ViralAntibodies, NeutralizingHumansCOVID-19 VaccinesEpitopesFemaleMiddle AgedAdultMaleMemory B Cells

Stichwörter der Autor:innen

BNT162b2CP: ImmunologyOmicronSARS-CoV-2breakthrough infectionimmune imprintingmemory B cellsneutralizing antibodyoriginal antigenic sin

Substanzen

Spike Glycoprotein, CoronavirusAntibodies, ViralAntibodies, Neutralizingspike protein, SARS-CoV-2COVID-19 VaccinesEpitopes

Autor:innen und Institutionen

  • BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • BioNTech, An der Goldgrube 12, 55131 Mainz, Germany; HI-TRON - Helmholtz Institute for Translational Oncology Mainz by DKFZ, Obere Zahlbacherstr. 63, 55131 Mainz, Germany.
  • BioNTech, An der Goldgrube 12, 55131 Mainz, Germany; TRON gGmbH - Translational Oncology at the University Medical Center of the Johannes Gutenberg University, Freiligrathstraße 12, 55131 Mainz, Germany. Electronic addr…

Zitieren

APA

Muik, A., Quandt, J., Lui, B. G., Bacher, M., Lutz, S., Grünenthal, M., Toker, A., Grosser, J., Ozhelvaci, O., Blokhina, O., Shpyro, S., Vogler, I., Salisch, N., Türeci, Ö., & Sahin, U. (2024). Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114567

Vancouver

Muik A, Quandt J, Lui BG, Bacher M, Lutz S, Grünenthal M, et al. Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114567

BibTeX
@article{Muik2024,
  author = {Muik, Alexander and Quandt, Jasmin and Lui, Bonny Gaby and Bacher, Maren and Lutz, Sebastian and Grünenthal, Maika and Toker, Aras and Grosser, Jessica and Ozhelvaci, Orkun and Blokhina, Olga and Shpyro, Svetlana and Vogler, Isabel and Salisch, Nadine and Türeci, Özlem and Sahin, Ugur},
  title = {Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2024.114567}
}
Kostenlos starten →